Steward Partners Investment Advisory’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Steward Partners Investment Advisory’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38	Closed	-$2K	–	3547
2020 Q4	$2K	Hold	38	–	–	﹤0.01%	2757
2020 Q3	$5K	Hold	38	–	–	﹤0.01%	2408
2020 Q2	$6K	Hold	38	–	–	﹤0.01%	2249
2020 Q1	$5K	Hold	38	–	–	﹤0.01%	2115
2019 Q4	$12K	Buy	38 +2	+6%	+$917	﹤0.01%	1966
2019 Q3	$18K	Buy	36 +24	+200%	+$13.5K	﹤0.01%	1771
2019 Q2	$7K	Buy	+12	New	+$7.36K	﹤0.01%	2140

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Steward Partners Investment Advisory's NBRV Position: Q1 2021 in Review

Steward Partners Investment Advisory sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2021, closing a stake of 38 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in NBRV in Q2 2019 and held it in 7 quarters. The position peaked at $18K in Q3 2019. 33 funds tracked by Wall St. Rank hold NBRV as of Q1 2021.

Steward Partners Investment Advisory reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2021 after selling out during the quarter.
Steward Partners Investment Advisory sold 38 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2021, an estimated $2K.
Steward Partners Investment Advisory first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2019 and held it in 7 quarters.
Steward Partners Investment Advisory's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $18K in Q3 2019.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2021, filed 14 May 2021.